The Medical Futurist
MAY 18, 2025
Here’s our overview to understand robotics in healthcare better so that everyone can prepare for the appearance of mechanic helpers in medical facilities. For this reason, we collected here the most useful robots in healthcare. These new ‘colleagues’ will definitely make a difference in every field of medicine.
California Academy of Family Physicians (CAFP)
MAY 14, 2025
This expansion would enable the state to: Secure an affordable and stable supply of both generic and brand-name drugs, Respond effectively to supply chain disruptions or politically motivated access restrictions, Protect access to medications such as mifepristone and other drugs threatened in other states.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Medical Futurist
JUNE 17, 2025
We’ve all been through this as a kid and childhood memories stick with us, just recalling this might send a shiver down your spine. No one likes to go to the dentist although everyone knows how crucial oral health is and how strongly it is connected to our overall health. For patients, it promises more accurate care and better outcomes.
FDA Law Blog
JULY 5, 2023
Under section 503B, drugs compounded by an FDA-registered outsourcing facility under the supervision of a licensed pharmacist can qualify for exemptions from FDA approval, labeling with adequate directions for use, and certain drug supply chain security requirements, subject to specific conditions. See 21 U.S.C. Draft Guidance III.B.2(d)
My Green Doctor
MAY 3, 2025
Medical waste is a broad term used to describe any waste products generated at healthcare facilities and includes everything ranging from the disposal of small needles to the energy consumption of radiologic scans. Single-use eye drops in ophthalmology operating rooms is just one example of the waste crisis in healthcare.
FDA Law Blog
OCTOBER 12, 2022
Most states have some form of naloxone standing order that allows a healthcare provider to write a prescription that covers a large group of people rather than just an individual patient. Because naloxone is a prescription drug, its distribution is subject to the requirements of the Drug Supply Chain Security Act (DSCSA).
FDA Law Blog
FEBRUARY 16, 2023
sales of naloxone from a wholesale distributor to a harm reduction program) from certain requirements under the Drug Supply Chain Security Act. All 19 members of the joint Advisory Committee agreed that the benefit-risk profile of Narcan Nasal Spray (NNS) is “supportive of its use as a nonprescription opioid overdose reversal agent.”
Expert insights. Personalized for you.
64 
Let's personalize your content